Foundayo 2.5mg film-coated tablets contain orforglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. It is a prescription-only medicine authorised in the UK for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes.

Foundayo works by activating GLP-1 receptors involved in appetite regulation and glucose metabolism. For weight management, it is used alongside a reduced-calorie diet and increased physical activity.

The 2.5mg strength is part of the prescribed dose-escalation schedule, following the initial 0.8mg dose, and should only be taken as directed by the prescribing healthcare professional.

Delivery and Returns

SKU: SK-01065 Category: Tags: , Brands:

Benefits

  • Oral GLP-1 treatment: Contains orforglipron in tablet form.
  • Weight management: Used alongside appropriate dietary and physical activity measures in eligible adults.
  • Blood glucose control: Also authorised for adults with insufficiently controlled type 2 diabetes.
  • Once-daily formulation: Taken according to the prescribed treatment plan.
  • Dose-escalation option: The 2.5mg strength is used after the initial treatment dose.

Features

  • Active ingredient: Orforglipron
  • Strength: 2.5mg per tablet
  • Pack size: 30 film-coated tablets
  • Administration: Oral
  • Dosing frequency: Once daily, as prescribed
  • Food restrictions: May be taken with or without food, at any time of day.
  • Treatment approach: Used alongside appropriate lifestyle measures.
  • Prescription status: Prescription-only medicine.

Why Choose

Foundayo provides an oral treatment option for eligible adults requiring medical management of weight or type 2 diabetes. Its active ingredient, orforglipron, acts on GLP-1 receptors involved in appetite regulation and glucose metabolism.

The 2.5mg tablet is an early dose in the prescribed treatment schedule. Treatment is individualised according to response, tolerability and clinical considerations, with dose changes made only in line with the prescribing information and advice from a healthcare professional.

Common Uses

Weight management: Used alongside a reduced-calorie diet and increased physical activity in adults with a BMI of 30kg/m² or above, or a BMI of 27–29.9kg/m² with at least one weight-related health condition.

Type 2 diabetes: Used alongside diet and exercise to improve blood glucose control in adults whose type 2 diabetes is insufficiently controlled. It may be prescribed alone when metformin is considered inappropriate or in combination with other diabetes medicines, as clinically appropriate.

How It Works

Foundayo contains orforglipron, a non-peptide GLP-1 receptor agonist. It activates GLP-1 receptors involved in appetite regulation and glucose metabolism.

Its effects include reducing food intake, supporting weight reduction and improving blood glucose control. It also delays gastric emptying, particularly after the initial dose, with this effect diminishing over time.

Foundayo should be used only as prescribed and alongside the lifestyle measures recommended by the treating healthcare professional.

What is Foundayo 2.5mg used for?
Foundayo is authorised for weight management in eligible adults and to improve glycaemic control in adults with insufficiently controlled type 2 diabetes. It is used alongside appropriate diet and physical activity measures.
What is the active ingredient in Foundayo?
The active ingredient is orforglipron, an oral GLP-1 receptor agonist.
How is Foundayo 2.5mg taken?
Foundayo is taken orally once daily, at any time of day, with or without food. Tablets should be swallowed whole. Patients should follow their prescribed instructions and must not change their dose without consulting their prescriber.
Is 2.5mg the starting dose?
No. The prescribed schedule starts at 0.8mg once daily. After at least 30 days, the dose may be increased to 2.5mg once daily, followed by further increases only as directed by the prescriber and according to response and tolerability.